PhotoPharmics
  • Clinical Pathway
  • Patient Experience
  • Pipeline
  • Team
  • About
    • Newsroom
    • Contact
Select Page

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Other News

  • PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
    September 16, 2021
  • PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer
    August 31, 2021
  • Utah-based PhotoPharmics Selected as Global Top 50 Startup
    June 24, 2021
  • PhotoPharmics Innovations Address Global Health Inequalities
    April 12, 2021
  • Phase 3 Trial Aims to Establish Non-Motor Improvement in Parkinson’s
    July 14, 2020

Articles & Insights

  • How Parkinson’s Affects Sleep and Vice-Versa
    How Parkinson’s Affects Sleep and Vice-Versa
    March 28, 2022
  • Care for the caregivers
    Care for the caregivers
    November 18, 2021
  • “Breaking Through the FDA” (Biosphere, 2021)
    “Breaking Through the FDA” (Biosphere, 2021)
    September 27, 2021
  • Answering some common questions about PhotoPharmics
    Answering some common questions about PhotoPharmics
    June 15, 2021
  • The importance of good diet and nutrition for people with Parkinson’s
    The importance of good diet and nutrition for people with Parkinson’s
    May 6, 2021

Quick Links

  • About Us
  • Team
  • Newsroom
  • Investor Inquiry
  • Contact Us

PHOTOPHARMICS, INC.

947 South 500 East, Suite 110
American Fork, UT 84003 USA

Phone
+1 (801) 770-6960

  • Facebook
  • Twitter
  • Instagram
© 2022 PhotoPharmics. All Rights Reserved.   |    Privacy Policy   |   Terms of Use